×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Principal Investigator  
Principal Investigator's Name: Andrew Jaffe
Institution: RBNC Therapeutics
Department: Data Science
Country:
Proposed Analysis: Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder with emerging genetic and molecular evidence in its etiology. Recent classes of methods have been developed to “impute” gene expression levels in hard-to-ascertain tissues like brain using just DNA sequence variation, for example prediXcan [PMID: 26258848] and TWAS [PMID: 26854917]. Importantly, these approaches impute expression levels within individual subjects using only common genetic variation from whole genome sequencing (WGS) or DNA microarrays, permitting disease-relevant downstream associations in richly-phenotyped clinical populations. While these algorithms have already published and publicly disseminated genotype/SNP “weights” to predict gene expression levels across all tissues in the Genotype By Tissue Expression (GTEx) project [PMID: 32913098], there have been few applications to AD. We therefore propose to apply existing GTEx – as well as our own custom - prediXcan weights from 11 different brain regions to genome-wide genotype data from ADNI and associate imputed expression levels with clinical traits related to symptom onset, severity, progression, and biomarker levels. We will also combine region-specific imputed expression levels in ADNI with parcellated neuroimaging data to add biological relevance and putative mechanisms for expression-trait associations as a form of multimodal analysis. These analyses together will identify novel genetic risk factors of AD and could inform new biomarkers and drug targets.
Additional Investigators  
Investigator's Name: Chris Wilks
Proposed Analysis: Responsible for genomic data processing and analysis
Investigator's Name: Joshua Burt
Proposed Analysis: Responsible for neuroimaging data processing and analysis
Investigator's Name: Tathagata Banerjee
Proposed Analysis: Responsible for integrative multimodal analyses of genomic and neuroimaging data
Investigator's Name: Oscar Rodriguez
Proposed Analysis: Same as main proposal
Investigator's Name: Oscar Rodriguez
Proposed Analysis: Same as main proposal
Investigator's Name: Nathan Posener
Proposed Analysis: Same as primary
Investigator's Name: Sathish Koduru
Proposed Analysis: Same as full proposal
Investigator's Name: Ayman Zeine
Proposed Analysis: Same as full proposal
Investigator's Name: Emily Burke
Proposed Analysis: Same as main analysis